Adicet Bio
ACET
ACET
102 hedge funds and large institutions have $467M invested in Adicet Bio in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 21 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 101 → 102 (+1)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
45% less call options, than puts
Call options by funds: $2.29M | Put options by funds: $4.17M
Holders
102
Holding in Top 10
6
Calls
$2.29M
Puts
$4.17M
Top Buyers
| 1 | +$29.3M | |
| 2 | +$21.1M | |
| 3 | +$4.13M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.75M |
| 5 |
BlackRock
New York
|
+$3.71M |
Top Sellers
| 1 | -$6.5M | |
| 2 | -$5.69M | |
| 3 | -$4.99M | |
| 4 |
Two Sigma Investments
New York
|
-$4.47M |
| 5 |
D.E. Shaw & Co
New York
|
-$3.12M |